Cargando…
Drug Eruptions: An 8-year Study Including 106 Inpatients at a Dermatology Clinic in Turkey
BACKGROUND: Few clinical studies are found in the literature about patients hospitalized with a diagnosis of cutaneous drug eruption. AIMS: To determine the clinical types of drug eruptions and their causative agents in a hospital-based population. MATERIALS AND METHODS: This retrospective study was...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371522/ https://www.ncbi.nlm.nih.gov/pubmed/22707770 http://dx.doi.org/10.4103/0019-5154.96191 |
_version_ | 1782235215370911744 |
---|---|
author | Akpinar, Fatma Dervis, Emine |
author_facet | Akpinar, Fatma Dervis, Emine |
author_sort | Akpinar, Fatma |
collection | PubMed |
description | BACKGROUND: Few clinical studies are found in the literature about patients hospitalized with a diagnosis of cutaneous drug eruption. AIMS: To determine the clinical types of drug eruptions and their causative agents in a hospital-based population. MATERIALS AND METHODS: This retrospective study was performed in the Dermatology Department of Haseki General Hospital. Through 1751 patients hospitalized in this department between 2002 and 2009, inpatients diagnosed as drug eruption were evaluated according to WHO causality definitions. 106 patients composed of probable and possible cases of cutaneous drug eruptions were included in this study. RESULTS: Seventy one females and 35 males were evolved. Mean age was 44.03±15.14. Duration between drug intake and onset of reaction varied from 5 minutes to 3 months. The most common clinical type was urticaria and/or angioedema in 48.1% of the patients, followed by maculopapular rash in 13.2%, and drug rash with eosinophilia and systemic symptoms in 8.5%. Drugs most frequently associated with cutaneous drug eruptions were antimicrobial agents in 40.5% of the patients, followed by antipyretic/anti-inflammatory analgesics in 31.1%, and antiepileptics in 11.3%. CONCLUSION: Urticaria and/or angioedema and maculopapular rash comprised majority of the drug eruptions. Rare reactions such as acute generalized exanthematous pustulosis, sweet syndrome, oral ulceration were also found. Antimicrobial agents and antipyretic/anti-inflammatory analgesics were the most commonly implicated drugs. Infrequently reported adverse reactions to myorelaxant agents, newer cephalosporins and fluoroquinolones were also detected. We suppose that studies on drug eruptions should continue, because the pattern of consumption of drugs is changing in every country at different periods and many new drugs are introduced on the market continuously. |
format | Online Article Text |
id | pubmed-3371522 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-33715222012-06-15 Drug Eruptions: An 8-year Study Including 106 Inpatients at a Dermatology Clinic in Turkey Akpinar, Fatma Dervis, Emine Indian J Dermatol Original Article BACKGROUND: Few clinical studies are found in the literature about patients hospitalized with a diagnosis of cutaneous drug eruption. AIMS: To determine the clinical types of drug eruptions and their causative agents in a hospital-based population. MATERIALS AND METHODS: This retrospective study was performed in the Dermatology Department of Haseki General Hospital. Through 1751 patients hospitalized in this department between 2002 and 2009, inpatients diagnosed as drug eruption were evaluated according to WHO causality definitions. 106 patients composed of probable and possible cases of cutaneous drug eruptions were included in this study. RESULTS: Seventy one females and 35 males were evolved. Mean age was 44.03±15.14. Duration between drug intake and onset of reaction varied from 5 minutes to 3 months. The most common clinical type was urticaria and/or angioedema in 48.1% of the patients, followed by maculopapular rash in 13.2%, and drug rash with eosinophilia and systemic symptoms in 8.5%. Drugs most frequently associated with cutaneous drug eruptions were antimicrobial agents in 40.5% of the patients, followed by antipyretic/anti-inflammatory analgesics in 31.1%, and antiepileptics in 11.3%. CONCLUSION: Urticaria and/or angioedema and maculopapular rash comprised majority of the drug eruptions. Rare reactions such as acute generalized exanthematous pustulosis, sweet syndrome, oral ulceration were also found. Antimicrobial agents and antipyretic/anti-inflammatory analgesics were the most commonly implicated drugs. Infrequently reported adverse reactions to myorelaxant agents, newer cephalosporins and fluoroquinolones were also detected. We suppose that studies on drug eruptions should continue, because the pattern of consumption of drugs is changing in every country at different periods and many new drugs are introduced on the market continuously. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3371522/ /pubmed/22707770 http://dx.doi.org/10.4103/0019-5154.96191 Text en Copyright: © Indian Journal of Dermatology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Akpinar, Fatma Dervis, Emine Drug Eruptions: An 8-year Study Including 106 Inpatients at a Dermatology Clinic in Turkey |
title | Drug Eruptions: An 8-year Study Including 106 Inpatients at a Dermatology Clinic in Turkey |
title_full | Drug Eruptions: An 8-year Study Including 106 Inpatients at a Dermatology Clinic in Turkey |
title_fullStr | Drug Eruptions: An 8-year Study Including 106 Inpatients at a Dermatology Clinic in Turkey |
title_full_unstemmed | Drug Eruptions: An 8-year Study Including 106 Inpatients at a Dermatology Clinic in Turkey |
title_short | Drug Eruptions: An 8-year Study Including 106 Inpatients at a Dermatology Clinic in Turkey |
title_sort | drug eruptions: an 8-year study including 106 inpatients at a dermatology clinic in turkey |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371522/ https://www.ncbi.nlm.nih.gov/pubmed/22707770 http://dx.doi.org/10.4103/0019-5154.96191 |
work_keys_str_mv | AT akpinarfatma drugeruptionsan8yearstudyincluding106inpatientsatadermatologyclinicinturkey AT dervisemine drugeruptionsan8yearstudyincluding106inpatientsatadermatologyclinicinturkey |